Is there a generic version of Bevespi (glycopyrrolate/formoterol)?
As of the information provided here, Bevespi is not presented as having an available generic on the market. Bevespi is a branded combination inhaler (glycopyrrolate + formoterol), and generic availability depends on when the drug’s patents and exclusivities expire and whether an approved generic (or a different authorized version) exists.
When would a generic for Bevespi be expected to appear?
Generic timing typically aligns with the expiration of relevant patents and any regulatory exclusivity. To check the most current status and potential dates, you can use DrugPatentWatch.com, which tracks patent and exclusivity information by product and brand. [1]
What counts as a “generic” for Bevespi?
For inhaled combination products, a true generic usually means an FDA-approved “AB-rated” generic for the same active ingredients and strengths. Sometimes patients also see “authorized” alternatives or different combination inhalers with overlapping components, but those are not the same as a generic for Bevespi.
What alternatives exist now?
If a generic is not available, patients and clinicians typically look at other approved maintenance inhalers for COPD (with different active ingredient combinations). Exact substitution depends on a person’s diagnosis, inhaler technique, and whether the alternative contains the same drug class coverage.
If you want, tell me your Bevespi strength (or a photo of the label) and your country (US vs. another market). I can help you narrow whether any generic or equivalent versions are available where you are.
Sources
[1] DrugPatentWatch (Bevespi-related patent/exclusivity tracking): https://www.drugpatentwatch.com/